Scientists have genetically modified isolated microbes for decades. Now, using CRISPR, they intend to target entire microbiomes.

Saliva tests screen staff and students at University of Illinois; Study ranks species most susceptible to SARS-CoV-2 infection; COVID-19 clinical trials test drugs that inhibit kinin system

From therapeutics to gene transfer, bacteriophages offer a sustainable and powerful method of controlling microbes.

Leonard Hayflick has been unafraid to speak his mind, whether it is to upend a well-entrenched dogma or to challenge the federal government. At 86, he’s nowhere near retirement.

From a rapid molecular test for COVID-19 to tools that can characterize the antibodies produced in the plasma of patients recovering from the disease, this year’s winners reflect the research community’s shared focus in a challenging year.

Image: Courtesy of Mark Neysmith, © Gregor Reid GUT REACTION: Researchers have found that Lactobacillus GR-1 and RC-14 can penetrate Escherichia coli biofilms, multiply, and survive. The human body plays host to a complex and thriving microbial ecosystem of vast numbers of tiny creatures. Some of these species, already well studied, can cause disease. But a renewed appreciation is growing for many lesser-known species called probiotics that help maintain health and may have the pote

CuresNow, a coalition of scientists, patient groups, and entertainment executives recently launched an ad campaign to rally opposition to the Brownback-Landrieu bill that would criminalize all forms of research cloning ("Popular ad couple Harry and Louise are back, opposing Bush cloning ban," Wall Street Journal, April 24, 2002). The characters were featured in commercials that helped sink Bill Clinton's health care reform plan. In the current effort, the fictitious Louise refers to a bill that